Newbury Pharmaceuticals AB Logo

Newbury Pharmaceuticals AB

A hybrid pharmaceutical company focused on specialty drugs in the Nordic region.

NEWBRY | ST

Overview

Corporate Details

ISIN(s):
SE0015244884
LEI:
549300F7XHU3I8CWL373
Country:
Sweden
Address:
Medicon Village, 223 81 Lund

Description

Newbury Pharmaceuticals AB is a hybrid pharmaceutical company focused on specialty prescription drugs and branded medicines. The company's business model combines the capabilities of a marketing authorization holder with those of a specialized commercial partner. It builds its portfolio through global partnerships, in-licensing products, and acting as an exclusive distributor and local representative for other brands. The primary market focus is the Nordic region, with selective international sales. The product portfolio covers various therapeutic areas, including oncology and rare diseases. Newbury Pharmaceuticals manages the full commercialization process, including regulatory affairs, market access, supply chain, and marketing, to deliver medicines to patients and healthcare professionals.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2018-10-05 13:14
Edison Investment Research Limited: Edison issues outlook on NeuroVive Pharmace…
English 10.7 KB
2017-06-29 13:30
EQS-News: Edison Investment Research Limited: Edison issues initiation on Neuro…
English 11.1 KB

Automate Your Workflow. Get a real-time feed of all Newbury Pharmaceuticals AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Newbury Pharmaceuticals AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Newbury Pharmaceuticals AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-09-07 Karl Karlsson Other Buy 25,000 103,050.00 SEK
2022-09-06 Lars Minor Other Buy 7,000 28,010.50 SEK
2022-09-06 karl karlsson Other Buy 10,000 40,200.00 SEK
2022-09-06 Andrea Karnitschky Other Buy 10,000 3,900.00 EUR
2022-09-05 Andrea Karnitschky Other Buy 10,000 3,870.00 EUR
2022-09-01 karl karlsson Other Buy 5,000 22,700.00 SEK
2022-08-31 Karl Karlsson Other Buy 10,000 44,400.00 SEK
2022-08-16 ANIL OKAY Other Other 205,000 2,050.00 SEK
2022-06-02 Karl Karlsson Other Buy 10,000 75,990.00 SEK
2022-03-01 karl karlsson Other Buy 2,000 19,400.00 SEK

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.